USANA Health Sciences (USNA) Misses Q3 EPS by 5c; revises guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $19.12 +1.27%
EPS Growth %: -41.9%
Financial Fact:
Interest income: 338K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -41.9%
Financial Fact:
Interest income: 338K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.59, $0.05 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $213 million versus the consensus estimate of $227.79 million.
GUIDANCE:
USANA Health Sciences sees FY2023 EPS of $2.80-$3.05, versus the consensus of $3.13. USANA Health Sciences sees FY2023 revenue of $900-920 million, versus the consensus of $930 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Robinhood plans $2B convertible notes offering due 2029
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
